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data for selected environmental risk factors [e.g., benzo[a]pyrene 
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alcohol consumption] were recorded; factors identified as significantly 
higher (P <0.05) amongst case subjects compared to controls were 
identified. In order to assess associations for epigenetic alterations 
and HCC risk factors, serum DNA methylation of TSGs was quantified using 
high-resolution melting (HRM) analysis. Our results clearly indicate 
elevated methylation patterns for detoxification gene [glutathione-S-
transferase Pi (GSTP)] promoter regions in cases compared to control 
subjects. Additionally, GSTP promoter hypermethylation and B[a]P diol 
epoxide-albumin (BPDE-Alb) were positively correlated with HCC incidence. 
Our epidemiological and in vitro cell model studies indicated that GSTP 
promoter DNA methylation regulates this gene's expression. Moreover, GSTP 
also plays an important role in B[a]P detoxification and potential 
protective role against B[a]P-induced liver cell toxicity and hepato-
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Epidemiological studies implicate environmental risk factors and epigenetic 24 
alterations in the multistage process of hepatocellular carcinoma (HCC) development. 25 
However, associations between environmental factors and DNA methylation of 26 
tumour suppressor genes (TSGs) in HCC development remain ambiguous. 27 
Understanding how possible interactions influence risk may provide insights into the 28 
complexity of hepato-carcinogenesis. For this study, blood samples were collected 29 
from HCC patients (n=90) and healthy volunteers (n=99) from Xiamen (China) and 30 
data for selected environmental risk factors [e.g., benzo[a]pyrene (B[a]P), hepatitis B 31 
or C virus (HBV or HCV) infection, smoking and alcohol consumption] were 32 
recorded; factors identified as significantly higher (P <0.05) amongst case subjects 33 
compared to controls were identified. In order to assess associations for epigenetic 34 
alterations and HCC risk factors, serum DNA methylation of TSGs was quantified 35 
using high-resolution melting (HRM) analysis. Our results clearly indicate elevated 36 
methylation patterns for detoxification gene [glutathione-S-transferase Pi (GSTP)] 37 
promoter regions in cases compared to control subjects. Additionally, GSTP promoter 38 
hypermethylation and B[a]P diol epoxide-albumin (BPDE-Alb) were positively 39 
correlated with HCC incidence. Our epidemiological and in vitro cell model studies 40 
indicated that GSTP promoter DNA methylation regulates this gene’s expression. 41 
Moreover, GSTP also plays an important role in B[a]P detoxification and potential 42 
protective role against B[a]P-induced liver cell toxicity and hepato-carcinogenesis. 43 
 44 
Keywords: B[a]P; Case control study; DNA methylation; Epigenetic; GSTP; 45 
Hepatocellular carcinoma 46 



































































1. Introduction 48 
Hepatocellular carcinoma (HCC) is the 4
th
 most common cancer worldwide and 49 
a major cause of cancer-related deaths, especially in sub-Saharan countries, Southeast 50 
Asia and China. Incidence rates of HCC in China have increased to 30/100,000; this 51 
equates to approximately 55% of total worldwide cases (Chen et al., 2005, and Parkin 52 
et al., 2002). Epidemiological studies suggest that both environmental risk factors and 53 
genetic alterations are associated with HCC development (Chen et al., 2002, Johnson 54 
et al., 2010 and Lambert et al., 2011), but the precise underlying mechanism(s) 55 
leading to hepato-carcinogenesis remain unclear. 56 
HCC is considered as mostly an environmental-related cancer, with both viral 57 
and chemical carcinogen components implicated in its multistage process (Zhao et al. 58 
2010). Hepatitis B virus (HBV) or hepatitis C virus (HCV) infection is considered a 59 
major risk factor (Lambert et al., 2011). Apart from infection, environmental pollution 60 
or unhealthy lifestyle may also provide a direct exposure route to many toxins that 61 
destabilize genomic integrity and/or deregulate epigenetic markings. Among many 62 
pollutants, benzo[a]pyrene (B[a]P), a polycyclic aromatic hydrocarbon (PAH), has 63 
been reported to occur in the environment as result of incomplete combustion of 64 
organic materials. B[a]P is a pro-carcinogen and, systemically in humans, can be 65 
converted into reactive metabolites [e.g., B[a]P diol epoxide (BPDE)] by cytochrome 66 
P4501A1 (CYP1A1); such reactive metabolites covalently bind to DNA, potentially 67 
causing genomic alterations (Ko et al., 2004). Covalent interaction between BPDE 68 
and nucleophilic centres in DNA is thought to be a critical event in the initiation of 69 



































































instigate genomic and epigenomic alterations (Feng et al., 2002 and Tang et al., 71 
2012). 72 
Aberrant DNA methylation is widely documented as an important epigenomic 73 
event in the development and progression of many cancers, including HCC (Herceg 74 
2007, Huang et al., 2011, Lambert et al., 2011 and Zhang et al., 2007). Recent studies 75 
demonstrate that aberrant DNA methylation of specific TSG promoters (e.g., APC, 76 
GSTP, P15, SOCS-1 and RASSF1A) and global genomes have been frequently 77 
observed in HCC (Esteller et al., 2001, Lambert et al., 2011 and Yang et al., 2003). 78 
Hypermethylation of TSG CpG islands inhibit transcriptional initiation and silence 79 
expression of downstream genes; particularly, if detoxification genes are silenced, by 80 
allowing intracellular accumulation of toxins, this may facilitate the carcinogenesis 81 
process. However, the association between environment pollutants, epigenetic 82 
modifications and HCC risk remains unknown. Herein, we investigated a 83 
hospital-based case-control cohort resident in the middle of the South East coastline 84 
of China, a high HCC incidence belt (Xu et al., 2003). In addition, an in-vitro cell 85 
model was employed to assess the effects of B[a]P exposure and its association with 86 
detoxification gene promoter DNA methylation modifications and HCC development. 87 
 88 
2. Materials and methods 89 
2.1 Samples and clinical characteristics of participants 90 
Peripheral blood samples from newly diagnosed HCC patients (n=90) before 91 



































































Xiamen University, Xiamen Hospital of Traditional Chinese Medicine and the 174
th
 93 
hospital of the People’s Liberation Army. All the HCC cases were clinic patients who 94 
were determined by clinical and radiological evaluation not to suffer any other cancer 95 
types. Written informed consent was obtained from all participants. A structured 96 
questionnaire and survey was conducted, as previously described (Zhao et al., 2010). 97 
The structured questionnaire included participant demographics (e.g., sex, age, height, 98 
body weight, income, employment status and occupational history); additional 99 
information including history of cigarette smoking, alcohol consumption, disease, 100 
diabetes mellitus, physical activity and viral infection (HBV, HCV) were collected 101 
from the participants or clinical documents with the permission of related 102 
stakeholders (Niu et al., 2010 and Zhao et al., 2012). 103 
2. 2 Measurement of the serum benzo[a]pyrene diol epoxide-albumin (BPDE-Alb) 104 
Serum BPDE-Alb adducts, a widely used biomarker for B[a]P exposure, were 105 
measured using reverse-phase high performance liquid chromatography, as previously 106 
described (Islam et al., 1999). In brief, 4 mL blood from participants were collected 107 
into Na-heparin tubes, and plasma separated by centrifugation at 1200×g for 10 min. 108 
Plasma was obtained and precipitated with one volume of saturated ammonium 109 
sulfate overnight, followed by 15 min centrifugation at 1200×g. To 1 mL of 110 
supernatant, 10 μL of concentrated acetic acid was added. The solution was left at 111 
room temperature overnight followed by 15 min centrifugation at 1200×g. The 112 
precipitated albumin, was washed with 4 mL acetone:ethylacetate (1:1) to remove 113 



































































solubilized in 900 μL of 10 mM Tris-HCl/1.0 mM EDTA (pH 8.0); the protein 115 
concentration was then determined using the protein quantitative kit (Bio-Rad 116 
Laboratories, USA). To 900 μL albumin was added 100 μl of 1 M HCl, and this 117 
solution was incubated at 90℃ for 3 h. Water and methanol were added to a final 118 
volume of 5 mL, resulting in a 10% methanol solution. This solution was applied to 119 
pre-conditioned (5 ml methanol followed by 10 mL water) Sep-Pak C18 cartridges 120 
(Millipore, Milford, MA) followed by 10 ml washing with water and elution with 5 121 
ml of methanol. The eluent was evaporated at 45°C under a nitrogen stream and 122 
re-solubilized in 500 μL of 10% methanol. The samples were stored at -20°C until 123 
analysis. Post-hydrolysis, the samples were analyzed with HPLC. For each sample 124 
200 μL was injected. The separation was performed on a Nova-Pak C18 3.9×150 mm 125 
column (Waters, Milford, USA) with a flow rate of 1.0 mL/min within a Waters LC 126 
system (Waters, Milford, USA), equipped with a LC ﬂuorescence detector. The 127 
excitation wavelength was 341 nm and the emission was measured at 381 nm. 128 
B[a]P-tetrahydrotetrol was separated by a linear gradient of methanol and water, 30% 129 
methanol to 100% methanol in 17 min, 8 min at 100% methanol and then 10 min at 130 
30% methanol before the next injection. 131 
2.3 Treatment of cell lines with B[a]P 132 
To investigate the association between GSTP promoter region methylation 133 
status and GSTP expression, normal immortal human liver (L02) and lung 134 
adenocarcinoma (A549) cell lines were selected as in vitro models. Both L02 and 135 



































































Sciences (Shanghai, China) where they were characterized by mycoplasma detection, 137 
immunoperoxidase staining, DNA profiling and cell viability tests. Cell lines were 138 
immediately expanded and frozen so they could be restarted every 4 to 5 months 139 
from a frozen vial of the same batch of cells. Both cell lines were cultured in DMEM 140 
high-glucose medium (Hyclone, USA). Medium were supplemented with 10% FBS 141 
(Hyclone, USA), 100 unit/mL penicillin and 100 unit/mL streptomycin. L02 and 142 
A549 cells were collected for GSTP promoter methylation status analysis and GSTP 143 
mRNA expression. A549 cells were employed as a methylation analysis control. 144 
Toward B[a]P exposure experiments, L02 cells were exposed to 0.1, 1 or 10 145 
nM B[a]P (Sigma-Aldrich, St. Louis, Mo) or DMSO alone (vehicle control). 146 
Meanwhile, in order to explore the GSTP detoxification in B[a]P exposure, L02-cell 147 
GSTP promoter regions were de-methylated and gene expression restored with 5 μM 148 
5-aza-2'-deoxycytidine (DAC) for 2 days treatment prior to exposure to 0.1, 1 or 10 149 
nM B[a]P or DMSO alone (vehicle control). After three days incubation, all cells 150 
were harvested and used for DNA or RNA analyses. 151 
2.4 Serum cell-free and cultured cell DNA extraction, and bisulfite treatment 152 
To remove additional cellular nucleic acids attached to cell debris, aspirated 153 
serum samples were centrifuged at 16,000×g for an additional 10 min at 4℃ before 154 
DNA extraction. Cell-free DNA (i.e., circulating free) in the serum of participants was 155 
extracted using the QIAamp DNA minikit (Qiagen, Hilden, Germany), according to 156 
manufacturer’s instructions. Approximately, 200 ng DNA isolated from serum was 157 



































































Orange, CA, USA), according to manufacturer’s instructions; unmethylated cytosines 159 
are converted to uracil whereas methylated cytosines remain unchanged during the 160 
reaction. The modified DNA was eluted in elution buffer and used for quantification 161 
of DNA methylation. 162 
2.5 Quantitative DNA methylation measurement 163 
High-resolution melting (HRM) analysis was applied to quantitatively measure 164 
the methylation status of GSTP promoter regions. Herein, whole genome PCR 165 
amplification of monoclonal plasmid from bisulfite-modified CpGenome Universal 166 
Methylated DNA (Chemicon, Millipore, Billerica, MA, USA) and genomic DNA 167 
from peripheral blood mononuclear cells of normal individuals were selected as 168 
methylation and unmethylation controls, respectively. Both of the control plasmids 169 
were confirmed by Sanger sequencing before performing an experiment. Methylation 170 
standards were constructed by diluting 100% methylated control plasmid in a pool of 171 
unmethylated control plasmid at 100%, 75%, 50%, 25%, 10%, 5% and 0% ratios. 172 
PCR amplification and HRM analyses were performed on the LC 480, as adapted 173 
from a published protocol (Roche Applied Science, Germany). Primers used for HRM 174 
analysis are shown in Table 1. PCR was performed in a final 20 μL volume 175 
containing: 1 × ZymoTaq Premix (Zymo, USA), 250 nM of each primer, 2.5 mM 176 
SYTO-9 dye (Invitrogen, Carlsbad, USA) and 10 ng bisulfite-treated DNA template. 177 
The cycling conditions started with one cycle at 95°C for 10 min, followed by 60 178 
cycles at 95°C for 20 sec each, a touch-down at 64°C to 58°C for 20 sec (1°C/cycle), 179 



































































and continuous to 95°C at 25 acquisitions per 1°C. HRM data was analysed by using 181 
gene scanning software (Roche, Germany), as previously described (Stanzer et al., 182 
2010). The melting curves were processed with normalization and temperature 183 
shifting using LightCycler Software. Raw data were exported from the LightCycler 184 
and used to generate a standard curve by regression analysis. This standard curve was 185 
then used to calculate the methylation levels of samples. 186 
2.6 Bisulfite sequencing PCR analysis 187 
The alternative quantitative measure of GSTP methylation was conducted by 188 
bisulfite sequencing PCR (BSP) (Tian et al., 2012). Genomic DNA was 189 
bisulfite-modified before PCR. GSTP promoter regions were amplified using the 190 
sequencing primer (Table 1). The PCR product containing 38 sites was purified using 191 
a Wizard SV Gel and PCR Clean-up System (Promega, USA), and cloned into 192 
bacteria using the pMD® 18-T Vector (Takara, Japan). Individual clones were grown 193 
overnight and plasmid DNA was isolated with an E.Z.N.A.
TM 
Plasmid Mini Kit 194 
(Promega, USA) and sequenced. Ten to twelve clones were sequenced per group. 195 
Sequence results were analysed online by QUMA (http://quma.cdb.riken.jp) (Kumaki 196 
et al., 2008). 197 
2.7 RNA extraction and RT-PCR 198 
Total RNA was isolated from each cell lines using the High pure RNA isolation 199 
Kit (Roche, Germany), according to the manufacture's protocol. First-stand cDNA 200 
synthesis was performed with one microgram total RNA using PrimeScript RT 201 



































































random primers and oligo dT primer. RT-PCR was performed using the SYBR Green 203 
Master Mix reagents (Roche, Germany). Glyceraldehyde-3-phosphate dehydrogenase 204 
(GAPDH) was used as an internal reference gene. Primer sets used for amplification 205 
are shown in Table 1. 206 
2.8 Statistical analysis  207 
Statistical analyses were performed using SPSS 18 (SPSS Inc). Variable 208 
distributions were analysed by the nonparametric Mann-Whitney U-test for 209 
continuous variables and χ2-test for categorical variables. Due to the non-normal 210 
distribution, Spearman correlation coefficients of BPDE-Alb levels with GSTP 211 
methylation status were calculated. Unconditional multivariate logistic regression was 212 
performed for chemical pollutants, which were significantly (P <0.05) associated with 213 
HCC in the univariate analysis. Age, gender, BMI and other important HCC risk 214 
factors were adjusted using the likelihood-ratio test. Adjusted odds ratios (AOR) and 215 
95% confidence intervals (CI) were calculated by the maximum likelihood approach. 216 
The quantity assessment of two factors’ interaction was also investigated, as 217 
previously described (Källberg et al., 2006 and Zhao et al., 2010). 218 
 219 
3. Results 220 
 221 
3.1 Demographics and related information 222 
Demographic and clinical characteristics of study participants are shown in Table 223 
2. HCC cases and corresponding controls were well age-matched (57.8 ± 8.4 y vs. 224 
57.9 ± 8.8 y; P =0.96). The case cohort contained a higher proportion of male subjects, 225 



































































22.4 ± 3.6; P =0.01). Smoking and alcohol consumption subjects were higher among 227 
the cases as compared to controls. The incidence of HBV and HCV was markedly 228 
higher in cases than in controls (43.3% vs. 9.1% for HBV; 44.4% vs. 21.2% for HCV). 229 
The number of liver cirrhosis patients among cases was also higher compared to 230 
controls (Table 2). 231 
3.2 GSTP promoter methylation and B[a]P exposure levels 232 
Human GSTP promoter region flank (-226 ~ -78) included 17 CpG sites and/or 233 
(-226 ~ +84) included 38 CpG sites. To estimate GSTP promoter methylation levels, 234 
HRM PCR was performed on serum cell-free DNA. To test the sensitivity of the 235 
HRM assays, we used the standard dilution series as described in the Materials and 236 
Methods section. The HRM assay can offer sufficient sensitivity to distinguish the 237 
heterogeneous methylation pattern. This assay was able to detect 1% methylation 238 
DNA in a background of unmethylated DNA. The correlation coefficient was 0.9919 239 
(Figure 1). Furthermore, to verify the reliability of the HRM assays on serum DNA, 240 
we performed BSP assays to quantify the levels of methylation accurately. Figure 2 241 
demonstrates the concordance of the methylation status by the HRM and BSP assays. 242 
We applied HRM for GSTP promoter methylation to analyse the n=90 HCC and n=99 243 
normal serum cell-free DNA. The frequency distribution of GSTP methylation status 244 
was observed as: methylated (exhibited fully methylated peak, Figure 2), 245 
heterogeneous (exhibited only one broad methylated peak, Figure 2) and 246 
unmethylated (only exhibited fully unmethylated peak, Figure 2) in cases (42.2%, 247 



































































Table 2). The median DNA methylation levels of GSTP promoter regions in cases 249 
(1.62%) were significantly higher than those of controls (0) (P <0.001, Table 3). 250 
B[a]P exposure levels in cases were significantly higher than those of the control 251 
group (1.79 fmol/mg adduct vs. 1.51 fmol/mg adduct, P <0.001, Table 3). Meanwhile, 252 
we found a positive correlation between GSTP methylation and BPDE-Alb levels in 253 
all subjects (r =0.13, P =0.04). Nevertheless, the median BPDE-Alb exposure level in 254 
all methylated subjects (4.35 fmol/mg) was significantly higher than all unmethylated 255 
subjects (1.66 fmol/mg) (P =0.02), while, there was no significance between 256 
heterogeneous subjects (3.22 fmol/mg) and unmethylated subjects (1.66 fmol/mg) (P 257 
=0.15) as well as methylated subjects (4.35 fmol/mg) (P =0.82) (Figure 3). 258 
Logistic regression was applied to investigate possible associations between 259 
GSTP promoter methylation and B[a]P exposure. In the stratification interaction 260 
analysis, after adjustment in the models for confounding variables (i.e., age, BMI, sex, 261 
alcohol consumption, smoking, HBV, HCV and liver cirrhosis), there was a stronger 262 
association between BPDE-Alb adduct levels with HCC risk amongst GSTP-M/H 263 
subjects, i.e., methylated and heterogeneous. The AOR for GSTP-M/H subjects who 264 
exhibited both low and high BPDE-Alb adduct levels were markedly elevated (3.8 265 
with 95% CI 1.3-10.9; 8.4 with 95% CI 2.7-26.6, P <0.001, for trend see Table 4). 266 
3.3 GSTP detoxification in B[a]P exposure 267 
In the in vitro study, we investigated whether GSTP silencing is accompanied by 268 
promoter region hypermethylation. Two human cell (A549 and L02) lines were 269 



































































DAC-treated A549 cells; promoter region DNA was almost unmethylated, even 271 
following DAC treatment (Figure 4). However, GSTP is silenced in L02 cells and its 272 
promoter is hypermethylated (78.5%). After DAC treatment, GSTP expression was 273 
restored with a corresponding decrease in promoter region methylation (57.5%) 274 
(Figure 4). 275 
To investigate the action of GSTP on detoxification in B[a]P exposure, we 276 
further examined the differences in responses to low-dose B[a]P treatment between 277 
L02 and DAC-exposed L02 cells. The L02 cell GSTP promoter region exhibited 278 
hypermethylation, and gene expression was silenced. Contrary to this, DAC-exposed 279 
L02 cell GSTP promoter region hypomethylation was observed; gene expression was 280 
significantly induced by B[a]P. However, GSTP promoter methylation status was 281 
unchanged by B[a]P exposure (Figure 5). Despite differences in cell models, these 282 
observations were associated with similar trends in CYP1A1 expression induced by 283 
B[a]P exposure (Figure 6). However, B[a]P exposure significantly induced the 284 
detoxification gene (GSTP), oxidative stress response gene (HO-1), cell cycle 285 
regulation gene (TP53), DNA methyltransferases genes (DNMT1, DNMT3A and 286 
DNMT3B) and DNA mismatch repair genes (HMLH1 and HPMS2) expression in L02 287 
cells, while no significance was found in DAC-treated L02 cells (Figure 6). 288 
 289 
4 Discussion 290 
This case-control study demonstrates that BPDE-Alb adducts are significantly (P 291 



































































gene GSTP promoter region is hypermethylated in HCC serum samples. BPDE-Alb 293 
adducts are significantly correlated with GSTP methylation levels in this cohort. In 294 
addition, risk for HCC development was highest amongst those individuals who 295 
exhibited higher levels of BPDE-Alb adducts and GSTP hypermethylation. Our cell 296 
model experiments also suggest that loss of GSTP expression via hypermethylation 297 
results in elevated B[a]P-induced genomic and epigenomic toxicity. 298 
4.1 Environmental exposure of PAHs in HCC 299 
PAHs are ubiquitous environmental pollutants and emitted into surrounding 300 
environment (i.e., air, soil, water, etc.) via incomplete combustion of coal, oil, gas, 301 
wood, other carbon-containing organic materials and/or cigarette smoke. These 302 
ultimately result in human (or other organism, e.g., wildlife) exposure through direct 303 
(water, diet) or indirect (dust, air) routes (Su et al., 2014 and Wu et al., 2007). B[a]P is 304 
the prototypical PAH and categorized as a pro-carcinogen. The tumorigenic effects of 305 
B[a]P are likely mediated via metabolic activation by cytochrome P450 enzymes and 306 
epoxide hydrolase into the highly reactive electrophilic metabolite, BPDE; this 307 
ultimately forms adducts through covalent binding to DNA and/or albumin. 308 
PAH-albumin adducts have been used as a sensitive indicator of chronic low-level 309 
PAH exposure, due to lack of repair mechanisms for albumin as compared to DNA. 310 
PAH-albumin adducts can also reflect different routes of long-term exposure, and may 311 
account for inter-individual differences for uptake, distribution, metabolism, and 312 
elimination (Wu et al., 2007). PAH-albumin adducts have also been reported to be 313 



































































(Wu et al., 2007 and Zhao et al., 2010). One potential mechanism for PAHs in 315 
hepato-carcinogenesis is elevated production of oxidative stress. A previous study 316 
found PAH-albumin adducts significantly correlated with urinary 317 
8-oxo-7,8-dihydro-2'-deoxyguanosine, a predominant form of free radical-induced 318 
oxidative lesions (Autrup et al., 1999). In agreement with our previous findings, the 319 
levels of PAH-albumin and PAH-DNA adducts in HCC blood were significantly 320 
higher than those in samples from control subjects (Su et al., 2014 and Zhao et al., 321 
2010). However, this study infers that apart from exposure factors, diverse elimination 322 
routes and metabolic fate may exert important roles in determining BPDE-Alb adduct 323 
levels in human serum. Likewise, our results also reveal that BPDE-Alb adducts 324 
distribution is not gender specific and there appears to be no correlation with cigarette 325 
smoking. 326 
4.2 DNA epigenetic alterations in HCC 327 
Epidemiology data suggests that increased oxidative stress from chronic hepatitis 328 
virus infection and environmental chemical exposures are involved in the 329 
pathogenesis of HCC (Li et al., 2013 and Martin and Herceg, 2012). Viral infection 330 
and environmental toxicants generate chronic inflammation and induce DNA damage 331 
via reactive oxygen species (Martin and Herceg, 2012). Oxidative stress has also been 332 
reported to interfere with epigenetic mechanisms, which can recruit DNMTs and 333 
Snail-dependent pathway to promoter hypermethylation of several specific gene 334 
promoter regions and silence their expression (Hamilton, 2010 and Lim et al., 2008). 335 



































































in hepato-carcinogenesis. 337 
We employed HRM analysis, a highly sensitive and specific method for 338 
detection and quantification of DNA methylation. HRM technology robustly 339 
distinguishes promoter region DNA into fully methylated and heterogeneous status. 340 
The precision of the HRM quantitative approach was tested by BSP analyses, and 341 
both results were highly concordant (Figure 2). We observed a high frequency of 342 
GSTP hypermethylation in the HCC group (53.3%), agreeing with previous studies 343 
showing a methylation-associated inactivation of GSTP in liver tumours (Lambert et 344 
al., 2011, Yang et al., 2003 and Zhang et al., 2005). Additionally, we also found GSTP 345 
hypermethylation in a few control group participants. A possible explanation for these 346 
observations could be that epigenetic alternations are early events in carcinogenesis. 347 
The age factor may also influence DNA methylation modification (Lambert et al., 348 
2011), and all individuals in the cases cohort were slightly older than controls (57.8 vs. 349 
57.9 y). We also confirmed in an in vitro L02 cell study that GSTP expression is 350 
silenced due to the promoter region hypermethylation. The π class glutathione 351 
S-transferase (GSTP) is a family of phase Ⅱ enzymes that can conjugate GSH with 352 
various environmental etiological factors. It likely plays important roles in protecting 353 
cells against genomic damage mediated by a wide range of oxidants and electrophiles 354 
from inflammation and/or environmental exposure (Li et al., 2013 and Zhang et al., 355 
2005). The liver is the major organ for metabolism and detoxification, and silencing 356 
GSTP expression may result in accumulation of genotoxic agents and elevated 357 




































































 It is noteworthy that herein we focused on cell-free serum DNA, which is easily 360 
obtained and a non-invasive measure as opposed to traditional biopsied tumour tissue. 361 
Serum and/or plasma samples contain circulating cell-free DNA shed from the 362 
primary tumour tissue; this is a ready surrogate for genetic and epigenetic studies 363 
(Huang et al., 2011). DNA methylation modifications in plasma and/or serum samples 364 
are highly concordant with those in matched primary tumour specimens (Huang et al., 365 
2011 and Iyer et al., 2010). This study reports similar results for GSTP 366 
hypermethylation frequency (53.3%) when compared to three previous HCC studies 367 
(54%, 46% and 54%, respectively) (Lambert et al., 2011, Zhang et al., 2005 and Yang 368 
et al., 2003). 369 
4.3 Association between PAH exposure and GSTP methylation 370 
Considering that GSTP plays an important role in reactive electrophile 371 
metabolite elimination and antioxidant defence, we further examined the different 372 
groups categorized by GSTP promoter region methylation status using a stratified 373 
analyses. Subjects exhibiting hypermethylation presented with significantly higher 374 
PAH-albumin adducts compared to hypomethylated individuals. Additionally, risk of 375 
developing HCC was highest amongst individuals who exhibited hypermethylated 376 
GSTP and elevated burden of BPDE-Alb adducts. These results indicate that GSTP 377 
plays an important role in PAH detoxification in vivo. Previous in vitro studies have 378 
also confirmed that GSTP-transfected HepG2 cells are more resistant to PAH toxicity. 379 



































































insert-free vector acquire high levels of PAH-induced DNA damage via formation of 381 
PAH-DNA adducts (Hu et al., 1999). Epidemiology also suggests a significant 382 
association between GSTP promoter hypermethylation with AFB1-DNA adducts in 383 
HCC (Zhang et al., 2005). 384 
To investigate the GSTP protective mechanism against PAH exposure in liver 385 
cells, we employed the human liver L02 cell line and DAC-treated L02 cells as an in 386 
vitro model, exposed to low-dose B[a]P (≤10 nM). CYP1A1, which converts B[a]P 387 
into BPDE during phase I biotransformation, was induced by PAH exposure in both 388 
cell models. BPDE may then be detoxified by GSTP during phase II reactions. GSTP 389 
can determine BPDE levels, thus influencing resulting genotoxicity. However, 390 
detoxification of reactive metabolite was only observed in PAH-induced DAC-treated 391 
L02 cells. Our results indicate that GSTP hypermethylation results in gene silencing 392 
and loss of its protective function. Thus oxidative stress response gene Heme 393 
oxygenase-1 (HO-1), cell cycle regulation gene (P53), DNA methyltransferases genes 394 
(DNMT1, DNMT3A and DNMT3B) and DNA mismatch repair genes (HMLH1 and 395 
HPMS2) were significantly induced by B[a]P exposure. This infers that GSTP 396 
promoter region hypermethylation causes failure in catalysing GSH conjugation of 397 
BPDE and results in accumulation of PAH-Alb and/or PAH-DNA adducts. 398 
Herein, selection bias and information bias were stringently controlled for. 399 
Potential confounding factors were ruled out using stratiﬁed analysis or multiple 400 
factor analysis. There were some limitations in the present study. It is a retrospective 401 



































































disadvantages. Due to the relatively small sample size, these findings need to be 403 
conﬁrmed in a larger cohort study. Although epidemiological data were complimented 404 
with in vitro cell models, it remains difficult to identify the exact chronological order 405 
for the elevation in BPDE-Alb adducts and the hypermethylation of GSTP promoter 406 
region. However, environmental PAH exposure and GSTP methylation associated 407 
with the risk of developing HCC is observed. 408 
In conclusion, we observe that GSTP promoter region methylation in 409 
circulating-free DNA isolated from serum is positively associated with HCC risk and 410 
may serve as an early epigenetic susceptibility biomarker. In addition, there appears to 411 
be an associated effect of environmental PAH exposure and GSTP methylation on risk 412 
of developing HCC. However, the interaction between environmental exposure and 413 
epigenetic alteration on HCC risk requires further investigation. 414 
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Figure Legends 535 
 536 
Figure 1. High resolution melting  assay using serial dilution of methylated 537 
plasmid DNA（from 100% to 0%). (A) High resolution melting curve of standard 538 
serial dilutions of methylated GSTP promoter region; and, (B) values of relative 539 
signal were plotted against the percentage of methylation for each dilution to generate 540 
a typical standard curve. All the experiments were performed in duplicate. 541 
 542 
 543 
Figure 2. High resolution melting (HRM) and bisulfite sequencing PCR (BSP) 544 
analysis of GSTP promoter status in representative serum samples. (A) HRM 545 
curve of GSTP promoter methylated standard (red), unmethylated standard (green), 546 
unmethylated serum (black), methylated serum (yellow), fully methylated serum (blue) 547 
and heterozygous methylated serum (purple); (B) Representative BSP analysis of 548 
GSTP promoter fully methylated serum; (C) Representative BSP analysis of GSTP 549 
promoter unmethylated serum; (D) Representative BSP analysis of GSTP promoter 550 
methylated serum; and, (E) Representative BSP analysis of GSTP promoter 551 
heterozygous methylated serum. In B-E, each line represents one DNA strand; the 552 
numbers at the top of the parallel line identify the location of the cytosine at the CpG 553 





































































Figure 3. Distribution BPDE-Alb exposure level in GSTP promoter unmethylated, 557 
heterozygous and methylated groups. All individual divided into unmethylated, 558 
heterozygous and methylated groups. Bar indicates media, P for Mann-Whitney test. 559 
 560 
Figure 4. RT-PCR and BSP analysis of GSTP expression and methylation in A549 561 
cells, DAC-treated A549 cells, L02 cells and DAC-treated L02 cells. (A) GAPDH 562 
as internal reference. GSTP is normally expressed in A549 cells, silenced in L02 cells 563 
but is restored upon DAC treatment; (B) The CpG methylation rates (%) for GSTP 564 
CpGs -226 to +84 in the control and DAC-treated groups for A549 and L02 are 565 
shown, DAC significantly decreased GSTP promoter methylation levels and restored 566 
GSTP mRNA expression in L02 cells. 567 
 568 
Figure 5. BSP analysis of DAC-treated L02 cell GSTP promoter methylation 569 
status in response to 24 h different dose of B[a]P exposure. The CpG methylation 570 
rates (%) for GSTP promoter -226 to +84 in the DMSO control groups 61.6 ± 9.9% 571 
(A); 0.1 nM B[a]P groups 65.5 ± 8.7% (B); 1 nM B[a]P groups 61.1 ± 12.1% (C); and, 572 
10 nM B[a]P groups 60.3 ± 10.7% (D). L02 cells were treated with 5 μM 573 
5-aza-2'-deoxycytidine (DAC) for 2 days prior to exposure, and then exposed to 0.1, 1, 574 
10 nM B[a]P or with DMSO alone (vehicle). In A-D, each line represents one DNA 575 
strand; the numbers at the top of the parallel line identify the location of the cytosine 576 
at the CpG sites. The open circles are unmethylated CpGs the filled-in circles are 577 



































































 Figure 6. Real-time RT-PCR analysis of gene expression in L02 cells (A) and 579 
DAC-treated L02 cells (B) in response to B[a]P exposure. Asterisks (*) indicate 580 
significant difference (P <0.05) when compared to the control. Standard deviation is 581 
showed as the error bars, which arise from triplicate tests for all the four independent 582 
experiments. 583 
 584 
Table1. Sequence of primers used for HRM, quantitative RT-PCR and BSP analysias 
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Table2. Demographics and clinical characteristics in cases (n=90) and controls (n=99) 
 Characteristic Case (%) Control (%) χ2（P-value） 
General Sex    
 Male 76 (84.4) 60 (60.6) 13.3 (<0.001) 
 Female 14 (15.6) 39 (39.4)  
 Age (year)    
 <50 46 (51.1) 52 (52.5) 0.04 (0.85) 
 ≥50 44 (48.9) 47 (47.5)  
 BMI (kg/m
2
)   
 <24 74 (82.2) 70 (70.7) 3.5 (0.06) 
 ≥24 16 (17.8) 29 (29.3)  
Life style Smoking status    
 Non-smoking 40 (44.4) 63 (63.6) 8.4 (0.02) 
 Smoking 48 (53.3) 36 (36.3)  
 Missing 2 (2.2)   
 Alcohol consumption   
 None 56 (62.2) 75 (75.8) 11.8 (0.03) 
 Drinker 32 (35.6) 24 (24.2)  




HBV    
HBV(-) 51 (56.7) 90 (90.9) 29.2 (<0.001) 
HBV (+) 39 (43.3) 9 (9.1)  
HCV    
 HCV (-) 50 (55.6) 78 (78.8) 11.3 (<0.001) 
 HCV (+) 40 (44.4) 21 (21.2)  
 Liver cirrhosis    
 Cirrhosis (-) 72 (81.1) 99 (100) 20.8 (<0.001) 




Methylation status   
GSTP-U
a
 40 (44.4) 77 (77.8)  35.2 (<0.001) 
GSTP-H
a
 10 (11.1) 11 (11.1)  
GSTP-M
a
 38 (42.2) 6 (6.1)  
Missing 2 (2.2) 5 (5.0)  
GSTP methylation status was qualitatively determined by HRM PCR. 
a
M, fully methylated; H, heterogeneous; U, fully unmethylated.  
 
 
Table3. Serum pollutant concentrations and DNA methylation levels in the participants 




Table4. Multivariate logistic regression analysis of the interactions of GSTP epigenetic vs 
benzo[a]pyrene exposure in HCC risks 









Characteristic Case Control P 
 Mean   SD   Median Mean  SD  Median  
BPDE-Alb (fmol/mg adduct) 17.71 21.64 1.79 6.48 11.10 1.51 < 0.001 
GSTP (%) 12.79 23.38 1.62 2.17 11.16 0.00 < 0.001 
  Case Control Crude OR (95% CI) AOR
a
 (95% CI) 
GSTP BPDE-Alb     
GSTP-U Low 15 41 1.0 (reference) 1.0 (reference) 
GSTP-U High 24 36 1.1 (0.3-3.3) 1.1 (0.3-4.3) 
GSTP-H/M Low 19 7 4.4 (1.8-10.5) 3.8 (1.3-10.9) 
GSTP-H/M High 29 10 7.7 (3.0-19.6) 8.4 (2.7-26.6) 
    P-trend < 0.001 P-trend < 0.001 
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